Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/1991
03/14/1991DE3930206A1 Hypolipaemic pharmaceutical prods. - comprising combination of cholestyramine and drug of vibrate type
03/14/1991DE3930168A1 Pharmaceutical compsn. contg. colestyramine to reduce lipid - in micro:tablet form levels without unpleasant taste
03/14/1991CA2025162A1 Non-effervescent ibuprofen compositions
03/13/1991EP0416951A1 Medicaments comprising salmeterol and fluticason
03/13/1991EP0416842A1 Solid matrix system for transdermal drug delivery
03/13/1991EP0416837A1 Photoprotection compositions having reduced dermal irritation
03/13/1991EP0416804A1 External preparation containing amusulosin
03/13/1991EP0416773A2 Vitamin B12 composition
03/13/1991EP0416739A1 Pharmaceutical compositions containing penciclovir
03/13/1991EP0416722A2 Pharmaceutical compositions having differential drug release rate
03/13/1991EP0416698A1 Contrast media
03/13/1991EP0416678A1 Topical compositions containing Defibrotide
03/13/1991EP0416677A1 Compositions for topical cosmetic use containing depolymerized nucleic acids
03/13/1991EP0416575A2 Drug delivery compositions based on biological materials and methods for preparing such compositions
03/13/1991EP0416527A2 Prostaglandin-containing liposome preparations
03/13/1991EP0416232A2 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
03/13/1991EP0416137A1 Method for reducing skin irritation associated with drug/penetration enhancer compositions
03/13/1991EP0416011A1 Chemotherapeutic composition for aids
03/13/1991EP0415999A1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits
03/13/1991EP0415922A1 Integrity protected gelatin
03/13/1991CN1049787A Gastric retention device
03/12/1991WO1991003491A1 TGF-β PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION
03/12/1991US4999435 Cationic Surfactants, Drugs, Immunoassay
03/12/1991US4999417 Biodegradable polymer compositions
03/12/1991US4999379 Novel pharmaceutical compositions for topical application with systemic action
03/12/1991US4999375 Psoralen reagent compositions for extracorporeal treatment of blood
03/12/1991US4999348 Liquid crystal containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions
03/12/1991US4999344 Phosphatidyl treatment of rapidly proliferating cells
03/12/1991US4999342 Long lasting contraceptive suppository composition and methods of use
03/12/1991US4999226 Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
03/12/1991US4999200 Wetting, binding, and disintegration agents; laxative tablet
03/12/1991US4999199 Pharmaceutical formulations: liposomes incorporating aromatic polyene antibiotics
03/12/1991US4999198 Polyaphrons as a drug delivery system
03/12/1991US4999189 Sustained release oral suspensions
03/12/1991US4999188 Methods for embolization of blood vessels
03/12/1991US4999185 Cacao Husk Extract
03/12/1991CA2066228A1 Tgf-beta protein compositions for inhibition of cell proliferation
03/12/1991CA2024965A1 Preventive and therapeutic agent for hepatitis
03/12/1991CA2024939A1 Device for the continuous release of vitamin a in drinking water
03/12/1991CA2024887A1 Pharmaceutical preparations
03/12/1991CA1281289C Ultradense and more soluble and bioavailable preparation of calcium citrate
03/10/1991WO1991003249A1 Preparations containing colestyramine for reducing lipid levels
03/10/1991CA2065151A1 Preparations containing colestyramine for reducing lipid levels
03/09/1991WO1991003219A1 Solid matrix system for transdermal drug delivery
03/09/1991CA2024884A1 Photoprotection compositions having reduced dermal irritation
03/08/1991CA2024804A1 Prostaglandin-containing liposome preparations
03/08/1991CA2021874A1 Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility
03/07/1991WO1991003099A1 Compressed powder medicaments
03/07/1991WO1991002763A1 Polymeric materials
03/07/1991WO1991002543A1 Stabilized vaccine compositions
03/07/1991WO1991002532A2 Method for stimulating fibrinolytic effect
03/07/1991WO1991002519A1 Method for increasing the pharmaceutical effect of inositol phosphate and a composition with improved pharmaceutical effect
03/07/1991WO1991002518A1 Pharmaceutical compositions and a device for administering the same
03/07/1991DE4027143A1 Stabilising blood substitute emulsions contg. per:fluoro-hydrocarbon
03/07/1991DE4019062A1 Stabilising blood substitute emulsions contg. per:fluoro-hydrocarbon
03/07/1991DE4019061A1 New and known perfluorinated N-cycloalkyl cyclic amine derivs.
03/07/1991DE3929184A1 Oral dosage forms for angina treatment - contg. iso:sorbide di:nitrate
03/07/1991CA2065023A1 Stabilized vaccine compositions
03/07/1991CA2064882A1 Pharmaceutical compositions and a device for administering the same
03/06/1991WO1991003271A1 Apparatus for administering medicaments to mucosal tissue
03/06/1991WO1991003237A1 Compositions and methods of manufacture of oral dissolvable medicaments
03/06/1991WO1991003236A1 Transmucosal dosage form
03/06/1991EP0415671A2 Gastric retention device
03/06/1991EP0415656A2 Production of sorbitol coated comestible
03/06/1991EP0415522A1 Process for reducing the crystal size of ondansetron hydrochloride dihydrate
03/06/1991EP0415458A2 Use of retinoids for preventing and reducing the size of striae distensae lesions
03/06/1991EP0415430A1 Stable solutions of mitomycin C
03/06/1991EP0415326A1 Composition for foaming preparation
03/06/1991EP0415264A2 Process for the preparation of perfluorinated heterocyclic compounds and compounds prepared by this process
03/06/1991EP0415263A2 Stabilisation of perfluorocarbon emulsions and perfluorinated heterocyclic compounds usable as emulsion stabilising additives
03/06/1991EP0415087A1 Tampon for medical or hygienic purposes and its method of manufacture
03/06/1991EP0415055A2 Water-soluble pressure-sensitive skin adhesive
03/06/1991EP0414932A1 Chewing gum composition
03/06/1991EP0414920A1 Aerosol preparation for external use
03/06/1991EP0414815A1 Blood substitute
03/06/1991EP0414806A1 High ratio active agent:lipid complex.
03/06/1991EP0414757A1 An agent for desensitizing man and/or animals against an allergen
03/06/1991EP0414730A1 Luminide and macroluminide class of pharmaceuticals
03/06/1991EP0414663A1 Liposome continuous size reduction method and apparatus
03/06/1991CN1049593A Improved sorbitol coated comestible and method of preparation
03/06/1991CA2024587A1 Drug delivery compositions based on biological cells or components thereof and methods
03/05/1991WO1991003263A1 Contrast media
03/05/1991US4997904 Aromatic polyanhydride compositions
03/05/1991US4997856 Method of producing compacted dispersable systems
03/05/1991US4997819 Pullulan, amylopectin, or dextrin
03/05/1991US4997761 Phosphatidyl treatment of viral disease
03/05/1991US4997658 Method for enhancing the lowering of plasma cholesterol levels
03/05/1991US4997656 Adhesive for percutaneous administration
03/05/1991US4997655 Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
03/05/1991US4997654 Method for increasing salivation for xerostomia patients
03/05/1991US4997653 Method for treating endometriosis with topical preparations containing danazol
03/05/1991US4997652 Drug delivery
03/05/1991US4997651 Pharmaceutical formulations
03/05/1991US4997643 Polymeric salt delivery systems
03/05/1991US4997454 Precipitation
03/05/1991US4997443 Reversible gel polymer
03/05/1991CA2064880A1 Contrast media
03/05/1991CA2024438A1 External preparation containing amusulosin
03/05/1991CA1280977C Polyprenyl alcohol-containing injections
03/05/1991CA1280976C Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thusobtained